[1] Goldoni S, Iozzo RA, Kay P, et al.A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity[J]. Oncogene,2007, 26(3):368-381.
[2] Yousefi M, Li N, Nakauka-Ddamba A, et al.Msi RNA-binding proteins control reserve intestinal stem cell quiescence[J]. J Cell Biol,2016,215(3):401-413.
[3] van der Flier LG, Haegebarth A, Stange DE, et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells[J]. Gastroenterology,2009,137(1):15-17.
[4] Gracz AD, Ramalingam S, Magness ST.Sox9 expression marks a subset of CD24-expressing small intestine epi-thelial stem cells that form organoids in vitro[J]. Am J Physiol Gastrointest Liver Physiol,2010,298(5):G590-G600.
[5] Schepers AG, Snippert HJ, Stange DE, et al.Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas[J]. Science,2012,337(6095):730-735.
[6] Barker N, Clevers H.Lineage tracing in the intestinal epithelium[J]. Curr Protoc Stem Cell Biol,2010,5(4):1-11.
[7] Yan KS, Chia LA, Li X, et al.The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations[J]. Proc Natl Acad Sci U S A,2012,109(2):466-471.
[8] Berndt JD, Moon RT.Cell biology. Making a point with Wnt signals[J]. Science,2013,339(6126):1388-1389.
[9] Farin HF, van Es JH, Clevers H. Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells[J]. Gastroenterology,2012,143(6):1518-1529.
[10] Qi Z, Li Y, Zhao B, et al.Bmp restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes[J]. Nat Commun,2017,8:13824.
[11] Haramis AP, Begthel H, van den Born M, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine[J]. Science,2004,303(5664):1684-1686.
[12] Cammareri P, Rose AM, Vincent DF, et al.Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma[J]. Nat Commun,2016,7:12493.
[13] Wiener Z, Band AM, Kallio P, et al.Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β[J]. Proc Natl Acad Sci U S A,2014,111(21):E2229-E2236.
[14] Carulli AJ, Keeley TM, Demitrack ES, et al.Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration[J]. Dev Biol,2015,402(1):98-108.
[15] Dignass AU, Sturm A.Peptide growth factors in the intestine[J]. Eur J Gastroenterol Hepatol,2001,13(7):763-770.
[16] Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer[J]. Nature,2012,487(7407):330-337.
[17] Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer[J]. Nature,2009,457(7229):608-611.
[18] Schwitalla S, Fingerle AA, Cammareri P, et al.Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties[J]. Cell,2013,152(1-2):25-38.
[19] Barker N, Clevers H.Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells[J]. Gastroenterology,2010,138(5):1681-1696.
[20] Snyder JC, Rochelle LK, Lyerly HK, et al.Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network[J]. J Biol Chem,2013,288(15):10286-10297.
[21] de Lau W, Barker N, Low TY, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling[J]. Nature,2011,476(7360):293-297.
[22] Chen PH, Chen X, Lin Z, et al.The structural basis of R-spondin recognition by LGR5 and RNF43[J]. Genes Dev,2013,27(12):1345-1350.
[23] Zebisch M, Xu Y, Krastev C, et al.Structural and mole-cular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin[J]. Nat Commun,2013,4:2787.
[24] de Lau W, Peng WC, Gros P, et al. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength[J]. Genes Dev,2014,28(4):305-316.
[25] Wakefield LM, Roberts AB.TGF-beta signaling: positive and negative effects on tumorigenesis[J]. Curr Opin Genet Dev,2002,12(1):22-29.
[26] Massague J.TGFbeta in cancer[J]. Cell,2008,134(2):215-230.
[27] Simms NA, Rajput A, Sharratt EA, et al.Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells[J]. BMC Cancer,2012,12:221.
[28] Liu XQ, Rajput A, Geng L, et al.Restoration of transforming growth factor-beta receptor Ⅱ expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo[J]. J Biol Chem,2011,286(18):16082-16090.
[29] van Meeteren LA, Goumans MJ, ten Dijke P. TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy[J]. Curr Pharm Biotechnol,2011,12(12):2108-2120.
[30] Cools N, van Tendeloo VF, Smits EL, et al. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells[J]. J Cell Mol Med,2008,12(2):690-700.
[31] Zhou X, Geng L, Wang D, et al.R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis[J]. Cancer Res,2017,77(23):6589-6602.
[32] Evans GS, Flint N, Somers AS, et al.The development of a method for the preparation of rat intestinal epithelial cell primary cultures[J]. J Cell Sci,1992,101(Pt 1):219-231.
[33] Sato T, Vries RG, Snippert HJ, et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a me-senchymal niche[J]. Nature, 2009,459(7244):262-265.
[34] Grabinger T, Luks L, Kostadinova F, et al.Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy[J]. Cell Death Dis,2014,5:e1228.
[35] Schwank G, Koo BK, Sasselli V, et al.Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients[J]. Cell Stem Cell,2013,13(6):653-658.
[36] Fumagalli A, Drost J, Suijkerbuijk SJ, et al.Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids[J]. Proc Natl Acad Sci U S A,2017,114(12):E2357-E2364.
[37] Papapetrou EP.Patient-derived induced pluripotent stem cells in cancer research and precision oncology[J]. Nat Med,2016,22(12):1392-1401.
[38] Usui T, Sakurai M, Enjoji S, et al.Establishment of a novel model for anticancer drug resistance in three-dimensional primary culture of tumor microenvironment[J]. Stem Cells Int,2016,2016:7053872.
